Cargando…
Pharmacogenomic testing and outcome among depressed patients in a tertiary care outpatient psychiatric consultation practice
The authors tested the hypothesis that pharmacogenomic genotype knowledge is associated with better clinical and cost outcomes in depressed patients, after controlling for other factors that might differentiate tested and non-tested patients. Medical records of 251 patients, seen in the Mayo Clinic...
Autores principales: | Rundell, J R, Harmandayan, M, Staab, J P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309479/ https://www.ncbi.nlm.nih.gov/pubmed/22832401 http://dx.doi.org/10.1038/tp.2011.7 |
Ejemplares similares
-
Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression
por: Winner, J, et al.
Publicado: (2013) -
Psychiatric pharmacogenomic testing in clinical practice
por: Mrazek, David A.
Publicado: (2010) -
Application of pharmacogenomics in psychiatric practice: The road ahead
por: Mohan, Prafull, et al.
Publicado: (2021) -
Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting
por: Cohn, Iris, et al.
Publicado: (2021) -
Psychiatric outpatient consultation for seniors. Perspectives of family physicians, consultants, and patients / family: A descriptive study
por: Yaffe, Mark J, et al.
Publicado: (2005)